Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
23-Jan-15 India’s medical electronics market will almost double to USD11.7 billion by 2017, growing at an annual rate of 16%, an SVP of Chennai’s Medall Diagnostics said recently. Increased awareness of healthcare delivery systems, lifestyle diseases, exploding population and increased middle-class income are the main drivers. “The future of electronics is in the field of healthcare”, he added. [image: Business Standard]Read More
02-Feb-15 A group of Indian healthcare operators, including Manipal Hospitals, Narayana Health and Pfizer, have got together with an investor to provide up to USD1.6 million in grants and investments to early-stage startups that seek to enhance access to affordable technology-driven healthcare products and services for the low-income population in India. [image: The Times of India]Read More
01-Feb-15 Brazil has plans to engage a medtech company to improve cardiology in state-sponsored hospitals. Medtronic sees an opportunity post-acquisition of Covidien, and plans to position itself as an entire cabinet supplier for cardiac surgery. "We feel you need to be bigger if you really want to be on the speed dial of the president of Brazil" a spokesperson said. [image: StarTribune/Bloomberg, Ariana Lindquist].Read More
01-Feb-15 Over ten years the Global Fund initiative in China has successfully addressed several major public health problems. Access to diagnosis and treatment of tuberculosis expanded from two pilot projects in 2006 to 92 sites in 30 provinces by 2013. Between 2002 and 2012 the number of malaria cases fell from over 100,000 to less than 5,000. Finally, China's rate of HIV infection was stabilised at 0.06%. [image: Snipview]Read More
31-Jan-15 Japan's Chugai Pharmaceutical will invest $476 million over the next seven years to expand its research institute in Singapore. The investment will make its centre at Biopolis one of the biggest pharmaceutical research and development operations in Singapore. It will also boost its "local employee base and antibody research and development pipeline", the company said. [image: Reuters]Read More
GGM is a research and advisory firm helping clients grow profitably in international markets.
We believe the only way to understand a market properly is on the ground. Intelligence from our in-country consultants gives you a competitive advantage in China, Asia, Latin America, the Middle East, Africa and other opportunity areas.
Our clients benefit from accurate data, reliable insights and strategic advice, giving them the confidence to make better business decisions and succeed in their global growth markets.
Enter your work email to receive our free GROW newsletter on international market intelligence and strategy.
Successful track record in your sector since 1992
In-country research consultants in over 40 markets
Value for money - quality results at affordable rates
Work led by senior directors with >20 years experience
Proven frameworks for data analysis and strategy
Pragmatic advice based on accurate data and reliable insights
Get in touch to discuss your growth markets research and advisory needs: